Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin:

MHHPA is, based on the available information (erythema score 2.00, oedema score 2.25), not a dermal irritant according to the Regulation (EC) No 1272/2008 (CLP). 

The conditions of the available study are more stringed, in particular the 24 hour exposure period compared with 4 hours of current test methods (described in OECD TG 404), and are thus regarded as worst case scenario. In conclusion the substance is not classified skin irritating based on CLP.

 

Eye:

Highly irritating and classified as Seriously eye damaging according to the Regulation (EC) No 1272/2008 (CLP) when 0.1 mL is applied to the rabbit eye.

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records
Reference
Endpoint:
skin irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Qualifier:
according to guideline
Guideline:
other: FHSA - 16CFR1500.41
Deviations:
no
Principles of method if other than guideline:
24 hour exposure period on abraded and intact skin. Treated sites examined for reaction to treatment 24 and 72 hours following exposure.
GLP compliance:
yes
Specific details on test material used for the study:
Lot/batch No.: 013
Species:
rabbit
Strain:
other: Albino
Type of coverage:
occlusive
Preparation of test site:
shaved
Vehicle:
not specified
Controls:
not required
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.5 g
Duration of treatment / exposure:
24 hours
Observation period:
72 hours
Number of animals:
6
Details on study design:
TEST SITE
- Area of exposure: 2.5 x 2.5 cm
- Test sites: One abraded, one intact site / animal
- Type of wrap if used: Test substance placed onto surgical gauze patches held in contact with the skin by adhesive tape. Trunk of the animal then wrapped with impervious tape for duration of exposure period

REMOVAL OF TEST SUBSTANCE
- Washing (if done): No data
- Time after start of exposure: 24 hours

SCORING SYSTEM: Draize scale
Scoring was done after 24 and 72 h.
Irritation parameter:
primary dermal irritation index (PDII)
Basis:
mean
Remarks:
of 6 animals
Time point:
24/48/72 h
Score:
4.4
Max. score:
8
Reversibility:
not specified
Remarks on result:
other:
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
mean
Remarks:
of 6 animals
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
mean
Remarks:
of 6 animals
Time point:
24/48/72 h
Score:
2.25
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
animal #1
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
animal #1
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
animal #2
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
animal #2
Time point:
24/48/72 h
Score:
2.5
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
animal #3
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
animal #3
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
animal #4
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
animal #4
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
animal #5
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
animal #5
Time point:
24/48/72 h
Score:
2.5
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
erythema score
Basis:
animal #6
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only
Irritation parameter:
edema score
Basis:
animal #6
Time point:
24/48/72 h
Score:
2.5
Max. score:
4
Reversibility:
not fully reversible within: 72 h
Remarks on result:
other: Intact skin
Remarks:
FHSA test - Observation at 24 & 72 hours only

Intact skin

Animal No.

Erythema

Oedema

24 hours

72 hours

24 hours

72 hours

1

2

2

2

2

2

2

2

2

3

3

2

2

2

2

4

1

3

1

3

5

2

2

2

3

6

2

2

2

3

Mean

2.0

2.3

 

Abraded skin

Animal No.

Erythema

Oedema

24 hours

72 hours

24 hours

72 hours

1

2

2

3

2

2

2

2

2

3

3

2

2

2

2

4

1

3

1

3

5

2

4

2

3

6

2

2

2

3

Mean

2.2

2.3

Interpretation of results:
GHS criteria not met
Conclusions:
Primary skin irritation has been investigated according to FHSA test methods. Based on the available information, (erythema score 2.00, oedema score 2.25), the substance is not a dermal irritant according to CLP (Regulation (EC) No 1272/2008).
The conditions of the available study are more stringed, in particular the 24 hour exposure period compared with 4 hours of current test methods (described in OECD TG 404), and are thus regarded as worst case scenario. In conclusion the substance is not classified skin irritating based on CLP.
Executive summary:
In a primary dermal irritation study, rabbits were dermally exposed to 0.5 mL of MHHPA for 24 hours. Reaction was assessed after 24 and 72 hours and assigned a numerical score according to the Draize scale.

A mean erythema score (24 - 72 hours), calculated over all 6 animals, for intact skin of 2.00 and for abraded skin of 2.33 was observed. The oedema score was determined to be 2.25 for intact skin and 2.67 for abraded skin.

Taking the test conditions into account, in particular the 24 hour exposure period compared with 4 hours of current test methods described in OECD TG 404, MHHPA has not to be classified and labelled as dermal irritant according to CLP (Regulation (EC) No 1272/2008).

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
the study need not be conducted because the substance is classified as irritating to eyes with risk of serious damage to eyes
Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Additional information

Skin:

In a primary dermal irritation study, rabbits were dermally exposed to 0.5 mL of MHHPA for 24 hours. Reaction was assessed after 24 and 72 hours and assigned a numerical score according to the Draize scale. A mean erythema score (24 - 72 hours),calculated over all 6 animals, for intact skin of 2.00 and for abraded skin of 2.33 was observed. The oedema score was determined to be 2.25 for intact skin and 2.67 for abraded skin. Taking the test conditions into account, in particular the 24 hour exposure period compared with 4 hours of current test methods described in OECD TG 404, MHHPA has not to be classified and labelled as dermal irritant according to CLP.

Eye:

MHHPA is classified as seriously eye damaging and CLP cites the need for hazard statement H318 (causes serious eye damage). Testing is waived based on the existing classification.

Justification for classification or non-classification

Based on the available data MHHPA was classified and labelled as Cat. 1, H318 causes serious eye damage, according to the Regulation (EC) No 1272/2008 (CLP).